A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The detection and measurement of antibodies to double-stranded (ds) DNA is important in the diagnosis and monitoring of patients with systemic lupus erythematosus (SLE). Several methods are available for their determination but none of them is completely satisfactory. Usually, purified dsDNA from different sources is used as antigen in the solid (enzyme-linked immunosorbent assay, ELISA) or liquid phase (Farr assay). Alternatively, anti-dsDNA antibodies can be demonstrated by immunofluorescence, using the haemoflagellate Crithidia luciliae (CLIFT). We have developed a new oligonucleotide-based anti-dsDNA ELISA in which dsDNA, constituted of a 5'photobiotinylated nucleic acid probe and its highly specific complementary oligonucleotide, is formed onto the solid-phase. To do that, a 40 bp probe is coated on the microplate wells via streptavidin-biotin bond and the in vitro (in solid-phase) developed hybrid between probe and its complementary helix used as capturing antigen. The assay has proved to be specific and the several experiments performed to ascertain the absence of single-stranded DNA (ssDNA) contamination and/or non specific binding to plastic, streptavidin, probe (without complementary chain) have all excluded any significant interference. To evaluate the clinical performance of this new assay, 114 serum samples from 68 SLE patients and 85 samples from 85 disease controls, in addition to 30 blood donors, were studied. The results were compared with commercial ELISAs, Farr assay and indirect immunofluorescence. The sensitivity and specificity were 66.2 and 96.4%, respectively, comparable and even better than those of the commercially available anti-dsDNA kits. Anti-dsDNA antibody levels, measured with the oligonucleotide-ELISA, correlated with SLE clinical activity determined using the European Consensus Lupus Activity Measurement (ECLAM) (r = 0.59, p < 0.0001). In conclusion, this assay has proved to be reproducible, and the results correlate well with other standard anti-dsDNA assays. The features of this new assay make it promising for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐DNA antibody tests
Kavanaugh, A. F., Solomon, D. H., & The American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines (2002) · Arthritis Care & Research · doi:10.1002/art.10558 · Cited by 225
The binding of antihistone antibodies to crithidia luciliae kinetoplasts is growth cycle‐dependent
Deng, J., Sontheimer, R. D., Lipscomb, M. F., & Gilliam, J. N. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280210 · Cited by 25
Cited by
Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 287
Antico, A., Platzgummer, S., Bassetti, D., Bizzaro, N., Tozzoli, R., Villalta, D., & Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL) (2010) · Lupus · doi:10.1177/0961203310362995 · Cited by 70
(2011) · PubMed · Cited by 41
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies
GHIRARDELLO, A., VILLALTA, D., MOROZZI, G., AFELTRA, A., GALEAZZI, M., GERLI, R., MATHIEU, A., MERONI, P. L., MIGLIORINI, P., RADICE, A., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.045 · Cited by 35
Self-citationAnti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review.
Orme, M. E., Voreck, A., Aksouh, R., & Schreurs, M. W. J. (2022) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab146 · Cited by 30
“In addition there were 15 studies (41, 46, 51–53, 55–59, 63–65, 68, 69) with test accuracy data for 16 different ELISA tests, with 11 studies (41, 42, 48, 49, 51, 54, 57, 60, 62, 65, 68) covering 9 different Farr-RIA tests and 2 studies (27, 49) covering 2 different Farr-FIA tests.”
Method
Metadata
- Authors
- Radice, A., & Sinico, R. A.
- Venue
- Autoimmunity
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 39
- Issue
- 2
- Pages
- 113-119
- ISSN
- 0891-6934 (ISSN-L)
- 1607-842X
- OpenAlex
- W2124176736
- Cited by
- 15
- References
- 3
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies. https://app.cochat.ai/papers/10.1080/08916930500448422
- The paper
- Radice, A., & Sinico, R. A. (2006). A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies. Autoimmunity. https://doi.org/10.1080/08916930500448422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.